Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aura Biosciences (AURA) Non-Current Deffered Revenue (2020)

Aura Biosciences filings provide 1 years of Non-Current Deffered Revenue readings, the most recent being $8000.0 for Q4 2020.

  • Quarterly Non-Current Deffered Revenue changed N/A to $8000.0 in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $8000.0 through Dec 2020, changed N/A year-over-year, with the annual reading at $8000.0 for FY2020, N/A changed from the prior year.
  • Non-Current Deffered Revenue hit $8000.0 in Q4 2020 for Aura Biosciences.
  • Across five years, Non-Current Deffered Revenue topped out at $8000.0 in Q4 2020 and bottomed at $8000.0 in Q4 2020.